TFDA ???????????? - PowerPoint PPT Presentation

About This Presentation
Title:

TFDA ????????????

Description:

... (Good Pharmacovigilance Practice GPvP) ... Pivotal clinical trials in Taiwan 2. REMS/RMP if necessary 1. Early phase clinical trials in Taiwan 2. REMS/RMP ... – PowerPoint PPT presentation

Number of Views:106
Avg rating:3.0/5.0
Slides: 53
Provided by: pacw150
Category:

less

Transcript and Presenter's Notes

Title: TFDA ????????????


1
TFDA ???????
?????????? ??? ??
2010.10.19 ??????
1
2
??
  • ??
  • ????????????
  • ???????????
  • ???????????
  • ????????
  • ???????????
  • ??/????

3
??????
  • ?????????????,??????
  • ??????????????,?????????
  • ???????????,???????????

3
4
????????????? ?????
-
4
5
?????????????
Post-Market Management
Pre-Market Approval
Research Discovery
Preclinical Testing
NDA
Market
IND
GPvP
GLP
IRB/GCP
ADR Reporting
Quality
ADR/SUSAR ? Reporting
Drug Injury Relief
Insurance
GTP
cGMP
?ADR/SUSAR adverse drug reaction/suspected
unexpected serious adverse reactions
5
5
6
??????????
  • 1982 ???????? (GMP)
  • 1983 ????????(PV,PMS)
  • ???????????????(BA/BE)
  • 1993 ??????
  • ?????????? (GCP)
  • 1998 ?????????????(GLP)
  • 1998 ????????????(ADR)
  • 2000 ??????????????(bridging study)
  • ?????(data exclusivity)
  • ?????????? Good Pharmacovigilance Practice
    (GPvP)
  • ??????????-????????????
  • ???????? (Drug Master File)
  • ??PIC/S GMP
  • 2010 ????????????
  • 2010 ?????????????????????(???)
  • ??????tNCE????????????(???)
  • 2010 ????CPP??(???)

6
7
Milestones on Drug Regulation
1980
2000
2010
1990
1982 GMP
1999 cGMP
2010 PIC/S GMP
2009 DMF
1987 BA/BE
1993 Local clinical trial
2000 Bridging Study Evaluation in accordance
with ICH E5
2001 Pivotal trial/ early phase trial
1998 GLP
1996 GCP
2010 TFDA
1998 CDE
2001 TDRF
1983 PV/PMS
1998 ADR
2008 GPvP
7
8
????????????
  1. ???????????
  2. ???????????
  3. ????????
  4. ???????????

8
8
9
??????????????
  • ??1??????
  • ??2???????????
  • ??3????????????
  • ??4?????????

9
9
10
??1??????
  • ??TFDA?????CDE??????????,????????
  • 99?1?1??,??????????,??????????
    (TFDACDE????)?????
  • 99?4???CDE??????TFDA ,?????????????

TFDA Taiwan Food and Drug Administration,
??????? CDE Center for Drug Evaluation,
???????????
10
10
11
??2???????????
  • ???????????????
  • ??TFDA?????????,???????
  • ?????????,???????????
  • ???????TFDA????????????????,??????

11
11
12
??3????????????
  • ???????QA/QC??,?????????????????????,???????????
  • ????????????
  • ?????????????,????????????
  • 99?8?10???????????????????????????,???????????????
    ?????????,?????????????
  • ??????????,????????approval letter?????????????,??
    ??approval letter????????(???99.09.30??????????)

12
12
12
13
??4-.?????????????
????
TFDA??
GMP/PMF?
??Global New???? ??Biosimilar?t-NCE?
??????? ??????????
????
????????
???????
??
? GMP Good manufacturing practice PMF Plant
master file
?????
13
13
14
?????????
  • ??????????????????(99?1??)
  • ????????????,???????????,????????????
  • ??????
  • Global New
  • ?????(?????),???????????
  • ????????????(Biosimilar)?t-NCE?
  • ????????????,?????????

??????? 98? 99?1-7?
????? 100 25
??99?1-7?????????22?,8?????,
???2????,??6??A?/??????
14
14
15
??????????????
10/6 ????
10/6 ????
  • (??????99?9?30???????????)

MOU Memorandum of Understanding
15
16
??4-.??????????(IND)????
?????(??????CRO)
TFDA??
??First-in Human ????????
??????????
????

??/?? ?????
??
?????
17
?????????????
  • (99?1??)
  • ????????First-in-human?????????,???????,????????
  • ?????????????????????????????,?????????
  • ????????????,?????????

????/??? (???) 98? 99?1-7?
????????? 11/189 (5.8) 0/118 (0)
???????? 62/67 (92.5) 0/8 (0)
? ????????????????
17
18
?????????????
  • ??????,???????????
  • ????FDA???????????IND/IDE,????????,????????????
  • ??????,??????,????????????????????????????,?IRB???
    ?,????????
  • ???????????????????????TFDA?CDE??????????????????

18
18
19
??4-.?????/???????
  • ?????????
  • 99?4?????????????????
  • 99?8?9????????????????????,???????????????
  • ?????????????????,?????????
  • ?????????
  • ??????99?3?15???????????
  • ???????????????????
  • ??????????????,?????????,???????????????,??????1/3
    ??????

19
19
20
??4-.??CTD???????(eCTD)??
  • ?????????????????????????????????????
  • ????????????????????????????????
  • ??????????????,?????????,?????????
  • ???????,?????????????,???????????????????,???????Q
    A?QC?

20
20
21
???????????????
  • ??1??????????
  • ??2??????????
  • ??3?????????????????
  • ??4????????????
  • ??5????????

21
21
22
??1-. ??????????
  • ???
  • 5?20???????????????????????
  • 7?12???????????????????????????
  • 7?19?????????????????106? ??
  • 10??????????????????????
  • ???
  • ???????? (99.9.30 ????????)

22
22
23
??1-.???????????? (????)
  • 99?5?20???????????????????????,????
  • ?????????????
  • ???????????
  • ????????????,?????????????
  • ??????????????????????

23
24
????????
  • ????????CPP??(??10?????)
  • ??t-NCE????(??12?????)
  • ??????????????(??11?????)
  • ?????????????
  • REMS (Risk Evaluation and Mitigation
    Strategy)(??12?????)
  • )

25
???????CPP??
  • ???????????(????CPP),??????????????,??????????
  • ?CPP???????,??????????????????
  • ?????????????????????????,????????
  • ???????????,?????????,??????????,?????????????

CPPCertificate of Pharmaceutical Product
25
25
25
26
???????CPP??
Non-CPP
1-CPP
2-CPP
Expected review time 720 days ( 2 years)
Expected review time 300 days
Expected review time 200 days

1. Early phase clinical trials in
Taiwan 2. REMS/RMP
1. Pivotal clinical trials in Taiwan 2.
REMS/RMP if necessary
1. REMS/RMP if necessary
?CPP Certificate for Pharmaceutical Product from
10 advanced countries ?REMS/RMP Risk Evaluation
and Mitigation Strategy/ Risk management
plan ?expected review time does not include the
time for document supplementation and bridging
study
26
27
??CPP?????
  • ??Non-CPP?????
  • ????
  • ??????????????
  • ???????????????????
  • ?????????????,????????
  • ??GCP?GLP????GMP??,????????????
  • ?????????????(REMS/RMP),?????????
  • ??????????????,?????????????,?????????????

GCP Good Clinical Practice GLP Good
Laboratory Practice
27
27
28
???????????
  • ??t-NCE????
  • T-NCE Taiwan New Chemical Entity
  • ???????????????????(???????)
  • ?????????????,?????????
  • ????????????????????,???????????
  • ??FDA???????505b2??,??2006?????t-NCE??,???????????
    ?
  • 99?8???t-NCE ????????????????checking list ??
  • ?????????????????
  • ???????????????,????????
  • ????????

28
28
29
???????????
  • ??????????????
  • ????????98?3????????????????????FDA????????????,??
    ???????,??????
  • 99?7???????????????-?????????????
  • ??99?9?28???????????,???????

29
29
29
30
???????????
  • ??????????????
  • ??EU?????????,???????????????????????????????
  • ???????????,??????????????????????? ? (8?27?????)
  • 102????????????,??????????????
  • 99?4???????????????

30
30
31
???????????
  • ?????????????
  • ?????????????????????????????????????????,?99?1??,
    ?TFDA?????
  • ????FDA???????,??????????????????,???????
  • ????????????????
  • ???????????????????,??????
  • ????????????????????

31
32
??2??????????
32
32
32
33
??????????????
  • Preclinical GLP inspection
  • Meet international standard
  • GCP inspection
  • Follow ICH
Write a Comment
User Comments (0)
About PowerShow.com